A Shedding Study of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF) Vaccine in Adults

计划入组 24 人 · 首次发布于 2019 年 1 月 7 日

A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF), With and Without Co-administration, in Adults Aged 60 Years and Older in Stable Health

计划入组 180 人 · 首次发布于 2017 年 11 月 13 日

A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older

计划入组 25,236 人 · 首次发布于 2021 年 6 月 1 日

Pre F protein (GlaxoSmithKline)

Pre F protein(GlaxoSmithKline Plc)

Pre-F VLP

Protein Sciences Corporation

United States

Casper, Dr Robert F

Canada

Schiff, Carl F MD

United States

WHO Includes ArkBio's Ziresovir in Pediatric RSV Drug Priority List, Marking First Chinese Anti-RSV Drug Recognition

FDA Updates: Approvals for RSV Vaccine, Pneumococcal Vaccine, and TB Drug Alongside Device Recalls

Innorna Completes Phase II Enrollment for World's First Bivalent RSV mRNA Vaccine